Skip to content
10-Q

Quarterly Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-22-002503

← back to feed
Filed
Nov 21, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 18, 2022 60.04M sh
Current Liabilities Q3 2022 · Sep 30, 2022 $144.96K
Current Liabilities Q3 2022 · Dec 31, 2021 $91.65K
Total Liabilities Q3 2022 · Sep 30, 2022 $151.48K
Total Liabilities Q3 2022 · Dec 31, 2021 $117.37K
Current Assets Q3 2022 · Sep 30, 2022 $607.43K
Current Assets Q3 2022 · Dec 31, 2021 $706.42K
Total Assets Q3 2022 · Sep 30, 2022 $643.65K
Total Assets Q3 2022 · Dec 31, 2021 $761.08K
Operating Cash Flow Q3 2022 · Sep 30, 2021 $359.84K
Stockholders Equity Q3 2022 · Sep 30, 2021 $568.22K
Stockholders Equity Q3 2022 · Jun 30, 2021 $640.21K
Stockholders Equity Q3 2022 · Mar 31, 2021 $628.88K
Stockholders Equity Q3 2022 · Dec 31, 2020 $685.87K
Sga Expense Q3 2022 · Sep 30, 2021 $867.21K
Sga Expense Q3 2022 · Sep 30, 2021 $1.19M
Rd Expense Q3 2022 · Sep 30, 2021 $2.12M
Rd Expense Q3 2022 · Sep 30, 2021 $2.77M
Net Income Q3 2022 · Sep 30, 2021 −$2.99M
Net Income Q3 2022 · Sep 30, 2021 −$3.85M
Net Income Q3 2022 · Jun 30, 2021 −$794.69K
Net Income Q3 2022 · Mar 31, 2021 −$59.49K
Operating Income Q3 2022 · Sep 30, 2021 −$2.99M
Operating Income Q3 2022 · Sep 30, 2021 −$3.84M
Gross Profit Q3 2022 · Sep 30, 2021 $0
Gross Profit Q3 2022 · Sep 30, 2021 $109.5K
Cost Of Revenue Q3 2022 · Sep 30, 2021 $0
Cost Of Revenue Q3 2022 · Sep 30, 2021 $490K